← Back to Search

Stigma Reduction Intervention for Acquired Immunodeficiency Syndrome

N/A
Waitlist Available
Led By Kumi Smith, PhD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This study is evaluating whether a quality of care intervention can reduce enacted stigma in healthcare settings.

Eligible Conditions
  • Acquired Immunodeficiency Syndrome
  • Human Immunodeficiency Virus Infection
  • HIV (Human Immunodeficiency Virus)

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality of Medical Care Questionnaire
Secondary outcome measures
HIV Testing Volume

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Stigma Reduction InterventionExperimental Treatment1 Intervention
A Stigma Reduction Intervention curriculum will be developed using data generated from Stage 1 of the study.
Group II: ControlActive Control1 Intervention
This study uses a modified Zelen design. Control arm participants will be aware that they are part of an observational study but not that they are in the control arm of an intervention study. This avoids artificially inducing changes to the standards of medical care in facilities randomization to the control arm, a common consequence in RCTs to evaluate population based services.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stigma Reduction Intervention
2020
N/A
~60

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,381 Previous Clinical Trials
1,551,228 Total Patients Enrolled
10 Trials studying Acquired Immunodeficiency Syndrome
7,256 Patients Enrolled for Acquired Immunodeficiency Syndrome
Kumi Smith, PhDPrincipal InvestigatorUniversity of Minnesota

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Standardized Patients to Measure and Address Intersectional Stigma
2020. "Standardized Patients to Measure and Address Intersectional Stigma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04896216.
~13 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top